Solution structure and dynamics of yeast elongin C in complex with a von hippel-lindau peptide 1 1Edited by M. F. Summers
- 1 September 2001
- journal article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 312 (1), 177-186
- https://doi.org/10.1006/jmbi.2001.4938
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Elongin BC complex prevents degradation of von Hippel-Lindau tumor suppressor gene productsProceedings of the National Academy of Sciences, 2000
- Transcription Elongation and Human DiseaseAnnual Review of Biochemistry, 1999
- Regulation of Hypoxia-Inducible mRNAs by the von Hippel-Lindau Tumor Suppressor Protein Requires Binding to Complexes Containing Elongins B/C and Cul2Molecular and Cellular Biology, 1998
- von Hippel-Lindau DiseaseMedicine, 1997
- The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteinsProceedings of the National Academy of Sciences, 1997
- SKP1 Connects Cell Cycle Regulators to the Ubiquitin Proteolysis Machinery through a Novel Motif, the F-BoxCell, 1996
- Binding of the von Hippel-Lindau Tumor Suppressor Protein to Elongin B and CScience, 1995
- Elongin (SIII): A Multisubunit Regulator of Elongation by RNA Polymerase IIScience, 1995
- Inhibition of Transcription Elongation by the VHL Tumor Suppressor ProteinScience, 1995
- Positive regulation of general transcription factor SIII by a tailed ubiquitin homolog.Proceedings of the National Academy of Sciences, 1995